Servicio Madrileño de Salud (SERMAS) is the public health provider of the region of Madrid. SERMAS belongs to the Spanish National Health System and provides services to more than 6 million citizens through 38 hospitals and 424 primary care centres. SERMAS is an international reference for high-specialized medicine; it is equipped with state-of-the art stage technologies and characterized by high-qualified health professionals distributed in three domains: primary care, hospital care and emergency care through SUMMA 112. SERMAS has one of the best public primary care systems in good coordination with hospital care and social services in order to provide integrated care and achieve real impact on patients and families. In order to improve health research management and coordination, SERMAS works with 13 Research Foundations that support from the economic and administrative point of view research and innovation that originates at university hospitals, primary care, the emergency medical service and public health covering all areas of specialties and including communication and information technologic departments. These public research foundations focus on innovation and translational research, seeking for real outcomes in healthcare. SERMAS is committed to ensure the continuous improvement of quality.

With a staff of over 51,700 professionals, the Catalan Health Institute (ICS) is the largest public health services company of Catalonia, that provides health care to nearly six million people across the country. As a reference entity of the public health system, the aim of ICS is to improve people’s health and quality of live, through the provision of excellent health services in his 8 Hospitals and 949 primary care centers and local consultancy, regarding both the promotion of health and the treatment of diseases, from the most prevalent to the most complex ones. Also, our organization includes research - 7 Institutes - , and education. All of our activities embrace innovation and knowledge transfer as a guarantee to continuously improve the attention that the institution offers to the citizens.

The Girona Biomedical Research Institute Dr. Josep Trueta (IDIBGI) is a CERCA research center of the Generalitat de Catalunya whose purpose is to promote, develop, transfer, manage and disseminate biomedical research, scientific and technological knowledge, teaching and training in the areas of life and health sciences, mainly in the Girona area.

Hospital Clinic of Barcelona (HCB), founded in 1906, is a university hospital with 4,500 professionals covering most of medical and surgical specialties. It belongs to the Catalan Public Hospital Network and it is both a high-complexity tertiary hospital and a community hospital providing services to more than half million citizens. HCB is placed in Spain in a top position in the areas of research and innovation (e.g. top participant in Societal Challenge 1-Health in H2020).

The Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a public research centre dedicated to biomedical research, founded in 1996 to broaden the clinical research of the Hospital Clinic de Barcelona (HCB). With >1,500 original articles and >2,500 publications annually, IDIBAPS is one of the leading biomedical research centres in Spain driving forward original multidisciplinary biomedical research on multiple diseases affecting our society, with the mission to translate “knowledge into cure”. The broad vision of IDIBAPS Strategic Plan is to improve the health and quality of life of citizens through high impact research and collaborations, at the highest level of scientific integrity, public accountability, and social responsibility. The close interaction of 100 clinical and laboratory research groups, composed by more than 460 Principal Investigators, drives forward original translational and multidisciplinary research oriented to solve relevant biological and clinical questions for human health. The researchers have access to novel and first-class infrastructures available together with six own core facilities offering a wide range of services under strict quality management controls performed at all levels. The institution has also a strong track record working in European projects (e.g. 90 projects obtained along H2020 and 36 in Horizon Europe) and has a dedicated European Projects Office (OPE) and the Knowledge and Technology Transfer Office (KTT).

The mission of the LUMC is ‘to be an innovator improving both healthcare and population health’. LUMC is a university medical center for research, education and patient care with a high quality profile and a strong scientific orientation. It has a unique research practice, ranging from pure fundamental medical research to applied clinical research. LUMC wants to perform ground-breaking innovation. Researchers, educators and healthcare providers at LUMC work together around 3 societal outreach topics, Oncology, Regenerative Medicine and Population Health. Furthermore 10 themes for innovation are defined Academic Pharma, Neuro Science, Cancer, (auto)Immunity, Cell, Tissue & organ, Cardio-Vascular, Genetics, infection, Life course and prevention and Lifestyle. https://strategie.lumc.nl/en/

NOVA University Lisbon has a strong commitment to health sciences that encompasses all its nine organic units - ranging from molecular biology to the health of populations. Three of NOVA’s schools are directly committed to health: NOVA Medical School, the Institute of Hygiene and Tropical Medicine and the National School of Public Health, while two others are dedicated to molecular biology and life materials as well as biomedical engineering, by so contributing to life sciences: the school of biotechnology and engineering (Faculty of Science and Technology) and the school of molecular biology (Institute of Chemical and Biological Technology António Xavier). Faculty of Social and Human Sciences, the school of management (Nova School of Business and Economics), the school of data (NOVA Information Management School) and the Law School, do collaborate to research in health sciences, namely covering social dimensions and interactions of health. We may rightly state that NOVA covers the entire health spectrum - from molecule to patient's bedside - linking fundamental biology, technology and health care to ultimately improve the health of populations. NOVAhealth platform mission is to create health value through scientific production, the dissemination of knowledge and the implementation of innovative solutions, useful for the health of populations. To fulfil this mission, we promote research collaborations between NOVA's academic units, as well as establish partnerships with industry and society, focused on research missions, with the identified purpose of responding to concrete problems. NOVAhealth is organized into ten research groups, where members of all NOVA organic units collaborate as well as other external members: Ageing, Nutrition, Value Improvement for Health and Care, Climate Change Impact on Public Health, Integrated Care, Migration and Health, Quality Improvement and Patient Safety, Health Systems and Policies and Tropical Health.

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care.